New Clinical Guidelines for operation and interpretation of Femoflor® test results are now available.
The new guideline contains extensive and up-to-date information on the application of Femoflor® 16 and Femoflor® Screen assays.
Real clinical cases from the practice have been examined with a detailed explanation of the results and their interpretation, as well as with a recommendations for conducting treatment.
Femoflor® is an advanced molecular diagnostic assay based on Real-Time PCR technology allowing complex analysis and assessment of female genitourinary microbiome, diagnosis of dysbiosis conditions and detection of sexually transmitted infections.
Femoflor® allows for quantitative assessment of normal and opportunistic microflora, including anaerobic microorganisms, whose detection is difficult by conventional microbiological methods.
In the new guide you will find:
- Clear definition of normocenosis and the different states of dysbiosis
- Guidelines for clinical behavior and interpretation of results in various states of dysbiosis
- Guidelines for clinical behavior and interpretation of results when establishing combined infections caused by several microorganisms